Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Clin Infect Dis. 2021 Apr 8;72(7):1220-1229. doi: 10.1093/cid/ciaa214.
Sepsis disproportionately affects allogeneic hematopoietic cell transplant (HCT) recipients and is challenging to define. Clinical criteria that predict mortality and intensive care unit end-points in patients with suspected infections (SIs) are used in sepsis definitions, but their predictive value among immunocompromised populations is largely unknown. Here, we evaluate 3 criteria among allogeneic HCT recipients with SIs.
We evaluated Systemic Inflammatory Response Syndrome (SIRS), quick Sequential Organ Failure Assessment (qSOFA), and National Early Warning Score (NEWS) in relation to short-term mortality among recipients transplanted between September 2010 and July 2017. We used cut-points of ≥ 2 for qSOFA/SIRS and ≥ 7 for NEWS and restricted to first SI per hospital encounter during patients' first 100 days posttransplant.
Of the 880 recipients who experienced ≥ 1 SI, 58 (6.6%) died within 28 days and 22 (2.5%) within 10 days of an SI. In relation to 10-day mortality, SIRS was the most sensitive (91.3% [95% confidence interval {CI}, 72.0%-98.9%]) but least specific (35.0% [95% CI, 32.6%-37.5%]), whereas qSOFA was the most specific (90.5% [95% CI, 88.9%-91.9%]) but least sensitive (47.8% [95% CI, 26.8%-69.4%]). NEWS was moderately sensitive (78.3% [95% CI, 56.3%-92.5%]) and specific (70.2% [95% CI, 67.8%-72.4%]).
NEWS outperformed qSOFA and SIRS, but each criterion had low to moderate predictive accuracy, and the magnitude of the known limitations of qSOFA and SIRS was at least as large as in the general population. Our data suggest that population-specific criteria are needed for immunocompromised patients.
脓毒症在异基因造血细胞移植(HCT)受者中发生率较高,且难以定义。用于脓毒症定义的临床标准可预测疑似感染(SI)患者的死亡率和重症监护病房终点,但在免疫功能低下人群中的预测价值尚不清楚。在此,我们评估了 3 项异基因 HCT 受者 SI 相关标准。
我们评估了 2010 年 9 月至 2017 年 7 月间移植的患者的全身炎症反应综合征(SIRS)、快速序贯器官衰竭评估(qSOFA)和国家早期预警评分(NEWS)与短期死亡率的关系。我们使用 qSOFA/SIRS≥2 和 NEWS≥7 作为切点,并将其限制在患者移植后 100 天内每个住院就诊时的首次 SI。
在经历≥1 次 SI 的 880 名受者中,58 名(6.6%)在 28 天内死亡,22 名(2.5%)在 10 天内死亡。在与 10 天死亡率相关方面,SIRS 的敏感性最高(91.3%[95%CI,72.0%-98.9%]),但特异性最低(35.0%[95%CI,32.6%-37.5%]),而 qSOFA 的特异性最高(90.5%[95%CI,88.9%-91.9%]),但敏感性最低(47.8%[95%CI,26.8%-69.4%])。NEWS 的敏感性(78.3%[95%CI,56.3%-92.5%])和特异性(70.2%[95%CI,67.8%-72.4%])适中。
NEWS 优于 qSOFA 和 SIRS,但每个标准的预测准确性均较低,且 qSOFA 和 SIRS 的已知局限性的程度至少与一般人群一样大。我们的数据表明,免疫功能低下患者需要特定人群的标准。